Signaling inputs to progesterone receptor gene regulation and promoter selectivity

Molecular and Cellular Endocrinology

Volumn 308, Issue 1-2, 2009, Pages 47-52

  Daniel, Andrea R ^a   Knutson, Todd P ^a   Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Phosphorylation; Progesterone receptor (PR); Promoter selectivity; Sumoylation; Transcription

Indexed keywords

EPIDERMAL GROWTH FACTOR; GESTAGEN; GLUCOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR SP1;

BREAST CANCER; BREAST DEVELOPMENT; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; GENE CONTROL; GENE REPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SUMOYLATION; TRANSCRIPTION REGULATION;

ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PREGNANCY; PROGESTINS; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 67349168694     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.01.004     Document Type: Review

References (47)

1. Abdel-Hafiz H., Takimoto G.S., Tung L., and Horwitz K.B. The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J. Biol. Chem. 277 (2002) 33950-33956
2. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 (2003) 419-427
3. Blind R.D., and Garabedian M.J. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J. Steroid Biochem. Mol. Biol. 109 (2008) 150-157
4. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Maller J.L., Miller W.T., and Edwards D.P. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8 (2001) 269-280
5. Bossis G., Malnou C.E., Farras R., Andermarcher E., Hipskind R., Rodriguez M., Schmidt D., Muller S., Jariel-Encontre I., and Piechaczyk M. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 25 (2005) 6964-6979
6. Brayman M.J., Julian J., Mulac-Jericevic B., Conneely O.M., Edwards D.P., and Carson D.D. Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells. Mol. Endocrinol. 20 (2006) 2278-2291
7. Brisken C., Park S., Vass T., Lydon J.P., O'Malley B.W., and Weinberg R.A. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 5076-5081
8. Chauchereau A., Amazit L., Quesne M., Guiochon-Mantel A., and Milgrom E. Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J. Biol. Chem. 278 (2003) 12335-12343
9. Cheng J., Bawa T., Lee P., Gong L., and Yeh E.T. Role of desumoylation in the development of prostate cancer. Neoplasia 8 (2006) 667-676
10. Chlebowski R.T., Hendrix S.L., Langer R.D., Stefanick M.L., Gass M., Lane D., Rodabough R.J., Gilligan M.A., Cyr M.G., Thomson C.A., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289 (2003) 3243-3253
11. Clemm D.L., Sherman L., Boonyaratanakornkit V., Schrader W.T., Weigel N.L., and Edwards D.P. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol. Endocrinol. 14 (2000) 52-65
12. Daniel A.R., Faivre E.J., and Lange C.A. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Mol. Endocrinol. 21 (2007) 2890-2906
13. Daniel A.R., Qiu M., Faivre E.J., Ostrander J.H., Skildum A., and Lange C.A. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72 (2007) 188-201
14. Faivre E.J., Daniel A.R., Hillard C.J., and Lange C.A. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol. Endocrinol. 22 (2008) 823-837
15. Faivre E.J., and Lange C.A. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol. Cell. Biol. 27 (2007) 466-480
16. Geiss-Friedlander R., and Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. 8 (2007) 947-956
17. Holmstrom S., Van Antwerp M.E., and Iniguez-Lluhi J.A. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 15758-15763
18. Horwitz K.B., Dye W.W., Harrell J.C., Kabos P., and Sartorius C.A. Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 5774-5779
19. Hudson L.G., Thompson K.L., Xu J., and Gill G.N. Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 7536-7540
20. Ishii S., Xu Y.H., Stratton R.H., Roe B.A., Merlino G.T., and Pastan I. Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 4920-4924
21. Ismail P.M., Amato P., Soyal S.M., DeMayo F.J., Conneely O.M., O'Malley B.W., and Lydon J.P. Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68 (2003) 779-787
22. Itani O.A., Liu K.Z., Cornish K.L., Campbell J.R., and Thomas C.P. Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5′-flanking region. Am. J. Physiol. 283 (2002) E971-E979
23. Jacobsen B.M., Schittone S.A., Richer J.K., and Horwitz K.B. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. Mol. Endocrinol. 19 (2005) 574-587
24. Jeong J.W., Lee K.Y., Kwak I., White L.D., Hilsenbeck S.G., Lydon J.P., and DeMayo F.J. Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. Endocrinology 146 (2005) 3490-3505
25. Kato S. Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer 8 (2001) 3-9
26. Kato S., Pinto M., Carvajal A., Espinoza N., Monso C., Sadarangani A., Villalon M., Brosens J.J., White J.O., Richer J.K., et al. Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1. J. Clin. Endocrinol. Metab. 90 (2005) 1181-1188
27. Labriola L., Salatino M., Proietti C.J., Pecci A., Coso O.A., Kornblihtt A.R., Charreau E.H., and Elizalde P.V. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol. Cell. Biol. 23 (2003) 1095-1111
28. Lange C.A. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?. Mol. Endocrinol. 18 (2004) 269-278
29. Lange C.A., Shen T., and Horwitz K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1032-1037
30. Lu N.Z., and Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 18 (2005) 331-342
31. Lu N.Z., and Cidlowski J.A. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol. 16 (2006) 301-307
32. Melchior F. SUMO-nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16 (2000) 591-626
33. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., Gong W., Beato M., and Auricchio F. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17 (1998) 2008-2018
34. Moore M.R., Zhou J.L., Blankenship K.A., Strobl J.S., Edwards D.P., and Gentry R.N. A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene. J. Steroid Biochem. Mol. Biol. 62 (1997) 243-252
35. Moore N.L., Narayanan R., and Weigel N.L. Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity. Steroids 72 (2007) 202-209
36. Owen G.I., Richer J.K., Tung L., Takimoto G., and Horwitz K.B. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 273 (1998) 10696-10701
37. Pierson-Mullany L.K., and Lange C.A. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol. Cell. Biol. 24 (2004) 10542-10557
38. Proietti C., Salatino M., Rosemblit C., Carnevale R., Pecci A., Kornblihtt A.R., Molinolo A.A., Frahm I., Charreau E.H., Schillaci R., et al. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol. Cell. Biol. 25 (2005) 4826-4840
39. Qiu M., and Lange C.A. MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association. J. Steroid Biochem. Mol. Biol. 85 (2003) 147-157
40. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., and Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277 (2002) 5209-5218
41. Shen T., Horwitz K.B., and Lange C.A. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol. Cell. Biol. 21 (2001) 6122-6131
42. Skildum A., Faivre E., and Lange C.A. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol. Endocrinol. 19 (2005) 327-339
43. Tseng L., Tang M., Wang Z., and Mazella J. Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biol. 22 (2003) 633-640
44. Tsutsui S., Ohno S., Murakami S., Hachitanda Y., and Oda S. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res. Treat. 71 (2002) 67-75
45. Wu H., Sun L., Zhang Y., Chen Y., Shi B., Li R., Wang Y., Liang J., Fan D., Wu G., et al. Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J. Biol. Chem. 281 (2006) 21848-21856
46. Yang S.H., Jaffray E., Hay R.T., and Sharrocks A.D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12 (2003) 63-74
47. Zhang P.J., Zhao J., Li H.Y., Man J.H., He K., Zhou T., Pan X., Li A.L., Gong W.L., Jin B.F., et al. CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome. EMBO J. 26 (2007) 1831-1842